{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:08:31Z","timestamp":1778562511995,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","award":["2018-2019"],"award-info":[{"award-number":["2018-2019"]}],"id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejpb.2025.114688","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:11:22Z","timestamp":1741878682000},"page":"114688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Artificial gut Simulator. A scheme to predict intestinal and plasma concentration\u2013time profiles of a weakly basic BCS-II drug, dipyridamole"],"prefix":"10.1016","volume":"210","author":[{"given":"Krutika Meena Harish","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishaan","family":"Duggal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao Helen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114688_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114513","article-title":"Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs","author":"Nyamba","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0010","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpb.2018.05.024","article-title":"Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption","volume":"129","author":"Kaur","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-015-9825-6","article-title":"Haste makes waste: the interplay between dissolution and precipitation of supersaturating formulations","volume":"17","author":"Sun","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114688_b0025","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1021\/mp400439q","article-title":"Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation","volume":"10","author":"Sun","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0030","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s11095-010-0213-8","article-title":"Predicting intestinal precipitation\u2013a case example for a basic BCS class II drug","volume":"27","author":"Carlert","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejpb.2016.03.024","article-title":"Matching phosphate and maleate buffer systems for dissolution of weak acids: equivalence in terms of buffer capacity of bulk solution or surface pH?","volume":"103","author":"Cristofoletti","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejpb.2015.05.015","article-title":"Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3","volume":"94","author":"Fuchs","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0045","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1208\/s12248-019-0292-3","article-title":"PBPK absorption modeling: establishing the In Vitro-In Vivo Link-Industry perspective","volume":"21","author":"Stillhart","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114688_b0055","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.xphs.2022.09.017","article-title":"An artificial gut\/absorption simulator: simultaneous evaluation of desupersaturation and absorption from ketoconazole supersaturated solutions","volume":"112","author":"Jain","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0060","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1021\/acs.molpharmaceut.3c01180","article-title":"An artificial gut\/absorption simulator: understanding the impact of absorption on in vitro dissolution, speciation, and precipitation of amorphous solid dispersions","volume":"21","author":"Jain","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0065","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11095-012-0844-z","article-title":"An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine","volume":"29","author":"Psachoulias","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/bdd.1803","article-title":"Mechanistic analysis of solute transport in an in vitro physiological two\u2010phase dissolution apparatus","volume":"33","author":"Mudie","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2025.114688_b0075","series-title":"The Quality Control of Medicines","first-page":"253","article-title":"In vitro studies on the dissolution and absorption behaviour of orally administered drugs, and the connection to their bioavailability","author":"Stricker","year":"1976"},{"key":"10.1016\/j.ejpb.2025.114688_b0080","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s11095-011-0399-4","article-title":"Influence of particle size on the ultraviolet spectrum of particulate-containing solutions: implications for in-situ concentration monitoring using UV\/Vis fiber-optic probes","volume":"28","author":"Van Eerdenbrugh","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2018.11.003","article-title":"Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport","volume":"292","author":"Wilson","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114688_b0090","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/jps.21068","article-title":"PAMPA\u2013critical factors for better predictions of absorption","volume":"96","author":"Avdeef","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0095","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.molpharmaceut.0c00040","article-title":"Ultrathin, Large-Area membrane diffusion cell for pH-dependent simultaneous dissolution and absorption studies","volume":"17","author":"Sinko","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.09.001","article-title":"Dynamic dissolution-\/permeation-testing of nano- and microparticle formulations of fenofibrate","volume":"96","author":"Sironi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0105","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.molpharmaceut.9b00406","article-title":"Prediction of bioequivalence and food effect using flux- and solubility-based methods","volume":"16","author":"Borbas","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0110","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1021\/acs.molpharmaceut.7b00740","article-title":"Absorptive dissolution testing of supersaturating systems: impact of absorptive sink conditions on solution phase behavior and mass transport","volume":"14","author":"Hate","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.molpharmaceut.8b01117","article-title":"Insight into amorphous solid dispersion performance by coupled dissolution and membrane mass transfer measurements","volume":"16","author":"Hate","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1208\/s12248-022-00721-1","article-title":"An artificial gut\/absorption simulator: description, modeling, and validation using caffeine","volume":"24","author":"Jain","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114688_b0125","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1021\/acs.molpharmaceut.7b00338","article-title":"Impact of drug-rich colloids of itraconazole and HPMCAS on membrane flux in vitro and oral bioavailability in rats","volume":"14","author":"Stewart","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0130","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/acs.molpharmaceut.7b00121","article-title":"Development of a biorelevant, material-sparing membrane flux test for rapid screening of bioavailability-enhancing drug product formulations","volume":"14","author":"Stewart","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0049-3848(83)90364-X","article-title":"Clinical pharmacokinetics of dipyridamole","volume":"29","author":"Bjornsson","year":"1983","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1211\/002235702847","article-title":"Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method","volume":"55","author":"Buchwald","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114688_b0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2009.02.002","article-title":"Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population","volume":"373","author":"Sugano","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0150","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/jps.22080","article-title":"Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay","volume":"99","author":"Skolnik","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0155","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114688_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105380","article-title":"Physiologically based pharmacokinetic model outputs depend on dissolution data and their input: case examples glibenclamide and dipyridamole","volume":"151","author":"Klumpp","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0165","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/acs.molpharmaceut.6b01063","article-title":"Utilization of gastrointestinal simulator, an in vivo predictive dissolution methodology, coupled with computational approach to forecast oral absorption of dipyridamole","volume":"14","author":"Matsui","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0170","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.xphs.2018.11.034","article-title":"Biopharmaceutic IVIVE-mechanistic modeling of single- and two-phase in vitro experiments to obtain drug-specific parameters for incorporation into PBPK models","volume":"108","author":"Pathak","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0175","unstructured":"Rohatgi A. WebPlotDigitizer User Manual 4.3. (http:\/\/arohatgi.info\/WebPlotDigitizer\/app\/)."},{"key":"10.1016\/j.ejpb.2025.114688_b0180","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114688_b0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gut.25.4.386","article-title":"Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine","volume":"25","author":"McCloy","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2025.114688_b0190","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s00464-008-0218-0","article-title":"Measurement of gastric pH in ambulatory esophageal pH monitoring","volume":"23","author":"Ayazi","year":"2009","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.ejpb.2025.114688_b0195","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the intellicap((R)) system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1211\/0022357022511","article-title":"Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine","volume":"56","author":"Kostewicz","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114688_b0205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.xphs.2018.11.006","article-title":"Molecular drivers of crystallization kinetics for drugs in supersaturated aqueous solutions","volume":"108","author":"Alhalaweh","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/clpt.1982.42","article-title":"Dipyridamol kinetics","volume":"31","author":"Mahony","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2025.114688_b0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0773.1979.tb02350.x","article-title":"Pharmacokinetics of dipyridamole","volume":"44","author":"Nielsen-Kudsk","year":"1979","journal-title":"Acta Pharmacol. Toxicol. (Copenh)"},{"key":"10.1016\/j.ejpb.2025.114688_b0220","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1208\/s12248-016-9966-2","article-title":"Regulatory experience with In Vivo In Vitro Correlations (IVIVC) in new drug applications","volume":"18","author":"Suarez-Sharp","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114688_b0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejps.2016.12.017","article-title":"Prediction of ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling","volume":"100","author":"Ruff","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114688_b0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.2042-7158.1991.tb06697.x","article-title":"Intestinal absorption of drugs. The influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat","volume":"43","author":"Poelma","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114688_b0235","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejpb.2020.03.019","article-title":"Effect of supersaturation on absorption of indomethacin and tadalafil in a single pass intestinal perfusion rat model, in the absence and presence of a precipitation inhibitor","volume":"151","author":"Strindberg","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:10:47Z","timestamp":1778559047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"alternative-id":["S0939641125000645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114688","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial gut Simulator. A scheme to predict intestinal and plasma concentration\u2013time profiles of a weakly basic BCS-II drug, dipyridamole","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114688"}}